{"id":903726,"date":"2025-10-31T12:03:26","date_gmt":"2025-10-31T16:03:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/"},"modified":"2025-10-31T12:03:26","modified_gmt":"2025-10-31T16:03:26","slug":"yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/","title":{"rendered":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon"},"content":{"rendered":"

<\/p>\n

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon<\/b><\/p>\n

Questions Company\u2019s Adjournment and Postponement of the Special Meeting Without Substantive Explanation<\/i><\/p>\n

STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting Process<\/i><\/p>\n

HONG KONG–(BUSINESS WIRE<\/a>)–
\nYunqi Capital Limited (together with its affiliates and the funds it advises, \u201cYunqi Capital\u201d), an investment management firm and 5.1% shareholder of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR\u2019s Special Meeting of Stockholders to vote on the proposed sale to Alcon Inc. (SIX\/NYSE:ALC) on the terms announced on August 5, 2025.<\/p>\n

\nThe text of the letter to the Board is as follows:<\/p>\n

\nOctober 31, 2025<\/p>\n

\nSTAAR Surgical Company
\n
25510 Commercentre Drive
\n
Lake Forest, CA 92630<\/p>\n

\nDear Members of the Board:<\/p>\n

\nWe are writing to express our deep concern regarding the Board\u2019s decision to postpone the special meeting of stockholders of STAAR to December 3, 2025. The Company\u2019s sudden adjournment of the special meeting scheduled for October 23 and this most recent postponement \u2013 both without any substantive explanation \u2013 indicate that the Board is attempting to revive a transaction that shareholders have already clearly signaled they do not support.<\/p>\n

Shareholders have already delivered their verdict.<\/span><\/b> Recent media coverage reported that, ahead of the special meeting scheduled for October 23, 2025, approximately 72% of STAAR\u2019s outstanding shares had voted against<\/span><\/b> the merger, and that approximately 81% had voted against<\/span><\/b> the $55 million compensation package for STAAR\u2019s executives.1<\/sup> In addition, all three leading proxy advisory firms \u2013 ISS, Glass Lewis, and Egan-Jones \u2013 have recommended voting against the merger. The Board\u2019s role is to act in the best interests of shareholders. Rather than respecting the overwhelmingly and clearly expressed will of the shareholder base, the Board appears to be prolonging a process that lacks shareholder support and is no longer viable.<\/p>\n

No progress has been disclosed from STAAR\u2019s latest discussions with Alcon.<\/span><\/b> The Company\u2019s most recent public filings reveal that STAAR and Alcon initiated renewed discussions in mid-October to consider \u201crecent developments and potential next steps.\u201d However, shareholders have seen no indication of actual progress in the way of improved terms. According to the Company\u2019s latest amendment to its proxy statement, as recently as October 24, 2025, Alcon had provided no commitment to increasing the consideration offered to shareholders. The only material development disclosed to shareholders has been the postponement of the special meeting to vote on the proposed merger. This lack of progress reinforces our concern that the current process and framework are not capable of producing the best value outcome for shareholders.<\/p>\n

The Board must now prioritize its fiduciary duties.<\/span><\/b> Continued delays create uncertainty, distract management, and risk further harm to the Company and its shareholders. The Board should not allow procedural maneuvering to substitute for sound judgment. We urge the Board to acknowledge the outcome that shareholders have already signaled and to take steps consistent with its fiduciary obligations to protect and enhance shareholder value.<\/p>\n

\nIt is also becoming increasingly clear that the Board\u2019s composition would benefit from additional shareholder perspective and membership of a director with meaningful economic interests in the Company. I would be pleased to serve on the Board with you to provide this perspective, and I would welcome conversations with you to that end.<\/p>\n

\nWe remain confident in STAAR\u2019s long-term prospects and its ability to deliver strong revenue growth and profitability. We respectfully request that the Board allow the proposed transaction with Alcon to be terminated in accordance with the direction already expressed by shareholders, and that STAAR move forward on a path to realize the significant value we believe the Company is capable of achieving.<\/p>\n

\nSincerely,<\/p>\n

\nChristopher M. Wang
\n
Founder and Chief Investment Officer
\n
Yunqi Capital Limited<\/p>\n\n\n\n
_______________\u00a0<\/td>\n<\/tr>\n
\n

1<\/sup> \u201cExclusive: Roughly 72% of STAAR Surgical Shares Oppose Alcon Deal, Vote Delayed,\u201d Yahoo Finance, Oct. 24, 2025, https:\/\/finance.yahoo.com\/news\/exclusive-roughly-72-staar-shares-175927651.html<\/a>.<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

About Yunqi Capital<\/b><\/p>\n

\nYunqi Capital is a Hong Kong headquartered investment manager with over US$250 million in assets under management. The firm deploys a fundamental long-short equity strategy, with a concentrated portfolio, that is primarily invested in the equity securities of companies with a significant China connection. Yunqi Capital is led by CIO Chris Wang, an experienced portfolio manager with a strong track record of generating attractive returns on capital, controlling portfolio risk and managing investment teams.<\/p>\n

Disclaimers<\/b><\/p>\n

\nTHIS IS NOT A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. DO NOT SEND US YOUR PROXY CARD OR OTHER VOTING INSTRUCTION FORM. YUNQI CAPITAL IS NOT ASKING FOR YOUR PROXY AND WILL NOT ACCEPT PROXY CARDS IF SENT. YUNQI CAPITAL IS NOT ABLE TO VOTE YOUR PROXY, NOR DOES THIS COMMUNICATION CONTEMPLATE SUCH AN EVENT.<\/p>\n

\nThis press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. This press release does not recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of the Company will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release and the discussions and opinions herein are for general information only, and are not intended to provide investment advice.<\/p>\n

\nThe information contained or referenced herein is for information purposes only in order to provide the views of Yunqi Capital and the matters which Yunqi Capital believes to be of concern to stockholders described herein. The information is not tailored to specific investment objectives, the financial situations, suitability, or particular need of any specific person(s) who may receive the information, and should not be taken as advice in considering the merits of any investment decision. The views expressed herein represent the views and opinions of Yunqi Capital, whose opinions may change at any time and which are based on analyses of Yunqi Capital and its advisors. In addition, the information contained herein is being publicly disclosed without prejudice and shall not be construed to prejudice any of Yunqi Capital\u2019s rights, demands, grounds and\/or remedies under any contract and\/or law.<\/p>\n

\nThis press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words \u201cexpects\u201d, \u201canticipates\u201d, \u201cbelieves\u201d, \u201cin our view\u201d, \u201cfrom our perspective\u201d, \u201cintends\u201d, \u201cestimates\u201d, \u201cplans\u201d, \u201cwill be\u201d, \u201cwould\u201d and similar expressions. Although Yunqi Capital believes that the expectations reflected in forward-looking statements contained herein are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties\u2014many of which are difficult to predict and are generally beyond the control of Yunqi Capital or the Company\u2014that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. In addition, the foregoing considerations and any other publicly stated risks and uncertainties should be read in conjunction with the risks and cautionary statements discussed or identified in the Company\u2019s public filings with the U.S. Securities and Exchange Commission, including those listed under \u201cRisk Factors\u201d in annual reports on Form 10-K and quarterly reports on Form 10-Q and those related to the pending transaction involving the Company. The forward-looking statements speak only as of the date hereof and, other than as required by applicable law, Yunqi Capital does not undertake any obligation to update or revise any forward-looking information or statements. Certain information included in this material is based on data obtained from sources considered to be reliable. Any analyses provided to assist the recipient of this material in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results. Accordingly, any analyses should not be viewed as factual and should not be relied upon as an accurate prediction of future results. All figures are unaudited estimates and, unless required by law, are subject to revision without notice.<\/p>\n

\nFunds and investment vehicles (collectively, the \u201cYunqi Funds\u201d) managed or advised by Yunqi Capital currently beneficially own shares of the Company. The Yunqi Funds are in the business of trading (i.e., buying and selling) securities and intend to continue trading in the securities of the Company. You should assume the Yunqi Funds will from time to time sell all or a portion of their holdings of the Company in open market transactions or otherwise, buy additional shares (in open market or privately negotiated transactions or otherwise), or trade in options, puts, calls, swaps or other derivative instruments relating to such shares. Consequently, Yunqi Capital\u2019s beneficial ownership of shares of, and\/or economic interest in, the Company may vary over time depending on various factors, with or without regard to Yunqi Capital\u2019s views of the pending transaction or the Company\u2019s business, prospects, or valuations (including the market price of the Company shares), including, without limitation, other investment opportunities available to Yunqi Capital, concentration of positions in the portfolios managed by Yunqi Capital, conditions in the securities markets, and general economic and industry conditions. Without limiting the generality of the foregoing, in the event of a change in the Company\u2019s share price on or following the date hereof, the Yunqi Funds may buy additional shares or sell all or a portion of their holdings of the Company (including, in each case, by trading in options, puts, calls, swaps, or other derivative instruments). Yunqi Capital also reserves the right to change the opinions expressed herein and its intentions with respect to its investments in the Company, and to take any actions with respect to its investments in the Company as it may deem appropriate, and disclaims any obligation to notify the market or any other party of any such changes or actions, except as required by law.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251031449492\/en\/<\/a><\/span><\/p>\n

\nChris Wang
\n
cwang@yunqipath.com<\/a><\/p>\n

KEYWORDS:<\/b> California Hong Kong United States North America Asia Pacific<\/p>\n

INDUSTRY KEYWORDS:<\/b> Finance Surgery Health Professional Services Optical<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Questions Company\u2019s Adjournment and Postponement of the Special Meeting Without Substantive Explanation STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting Process HONG KONG–(BUSINESS WIRE)– Yunqi Capital Limited (together with its affiliates and the funds it advises, \u201cYunqi Capital\u201d), an investment management firm and 5.1% shareholder of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR\u2019s Special Meeting of Stockholders to vote on the proposed sale to Alcon Inc. (SIX\/NYSE:ALC) on the terms announced on August 5, 2025. The text of … <\/p>\n

Continue reading “Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-903726","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nYunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Questions Company\u2019s Adjournment and Postponement of the Special Meeting Without Substantive Explanation STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting Process HONG KONG–(BUSINESS WIRE)– Yunqi Capital Limited (together with its affiliates and the funds it advises, \u201cYunqi Capital\u201d), an investment management firm and 5.1% shareholder of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR\u2019s Special Meeting of Stockholders to vote on the proposed sale to Alcon Inc. (SIX\/NYSE:ALC) on the terms announced on August 5, 2025. The text of … Continue reading "Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-31T16:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon\",\"datePublished\":\"2025-10-31T16:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/\"},\"wordCount\":1739,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/\",\"name\":\"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-10-31T16:03:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/","og_locale":"en_US","og_type":"article","og_title":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk","og_description":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Questions Company\u2019s Adjournment and Postponement of the Special Meeting Without Substantive Explanation STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting Process HONG KONG–(BUSINESS WIRE)– Yunqi Capital Limited (together with its affiliates and the funds it advises, \u201cYunqi Capital\u201d), an investment management firm and 5.1% shareholder of STAAR Surgical Company (\u201cSTAAR\u201d or the \u201cCompany\u201d) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR\u2019s Special Meeting of Stockholders to vote on the proposed sale to Alcon Inc. (SIX\/NYSE:ALC) on the terms announced on August 5, 2025. The text of … Continue reading \"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-31T16:03:26+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon","datePublished":"2025-10-31T16:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/"},"wordCount":1739,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/","name":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-10-31T16:03:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251031449492r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/yunqi-capital-issues-letter-to-staar-surgical-board-calling-for-termination-of-the-proposed-merger-with-alcon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/903726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=903726"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/903726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=903726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=903726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=903726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}